Back to 
UBS Group AG
UBS Group AG
ARTL1 quarters
Position history for UBS Group AG's holdings in ARTELO BIOSCIENCES INC
Yes. Ubs holds 2,804 shares of ARTL (Artelo Biosciences), worth $3,140, as of its Q2 2026 13F filing. It opened the position in Q2 2026.
Current Value
$3,140
Current Shares
2,804
Total Value Change
$0
Total Shares Change
0
Quarter-by-Quarter History
Other major holders of ARTL: JANE STREET GROUP, LLC, VANGUARD CAPITAL MANAGEMENT LLC, VANGUARD FIDUCIARY TRUST CO, CITIGROUP INC